Three to buy
Anexo Group
(Shares) This credit-hire and legal services firm could be an “Aim star in the making”. After motoring accidents, Anexo steps in to provide replacement- hire vehicles. Bond Turner, its legal side, deals with personal injury and negligence claims, among others, and is currently involved in a class-action case against Volkswagen over vehicle emissions. Cashflow remained resilient during lockdown, enabling Anexo to continue paying a dividend. Analyst Andrew Simms of Arden thinks the shares could more than double from here thanks to a growing market share and more investment in the legal division. 132p
Angling Direct
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
(Interactive Investor) This fishing-tackle supplier seems to be enjoying a pandemic boost as Britons turn to solitary, staycation-friendly sports. Revenue rose by 21% in the six months to 31 July despite the long closure of stores, with online traffic surging by 54%. Trading on the continent has also surged. There could be plenty of upside to come should this prove the start of a new trend. 60p
Taseko
(The Mail on Sunday) This Vancouver-based mining company is cashing in on copper as prices trade around a two-year high. The group has one site in production, with one more due to come online soon, as well as four other prospects. The outlook for copper remains buoyant: governments are using infrastructure projects to stimulate the economy, supporting metals demand. On the supply side, Chilean and Peruvian output has also been constrained by the virus. The shares offer a way for British investors to play structural demand for the essential industrial metal. 65p
Three to sell
Crest Nicholson
(Investors Chronicle) The UK housing market has been enjoying a surprise post-lockdown surge, but developers still expect lower prices later this year. This FTSE 250 housebuilder is among the most vulnerable because of its low operating margins. It remains exposed to the weak London market despite an ongoing effort to shift into regional, affordable housing. The shares are on a steep discount to forecast net asset value but bargain hunters should steer clear: two inventory write-downs since last November mark a worrying pattern. The short sellers are circling. 191p
Superdry
(The Sunday Times) In spring 2019 co-founder Julian Dunkerton seized back control of this struggling clothing business with the help of activist investors, vowing to revamp a “misguided strategy”. Yet since then the stock has declined by three-quarters. The pandemic has depressed trading but the brand’s reliance on “department stores and city centres”, the result of over-expansion in the good times, raises longer-term questions. A £57.8m cash pile may provide a temporary buffer, but it won’t cover losses forever. Avoid the shares. 135p
Synairgen
(Motley Fool UK) Shares in this small biotech have soared 38-fold this year on hopes for its SNG001 treatment in the fight against Covid-19. Positive trials are encouraging but SNG001 still has further clinical hurdles to clear. The group may also be forced to turn to a pharmaceutical giant to scale up production and distribution. Potential partners are likely to demand a handsome cut of the revenue, so the valuation looks optimistic. Avoid. 231p
....and the rest
The Daily Telegraph
Improving the economy’s energy efficiency is becoming a key priority for governments and businesses. Industry-leading Irish insulation specialist Kingspan is well-placed to profit from the trend (€64.60). Catalytic converter maker Johnson Matthey will lose out from the rise of electric vehicles, but its investments in battery technology and hydrogen mean investors should not unplug just yet. Hold (2,295p). IP Group helps commercialise the innovations of British academics. Such early-stage investments are risky, but the portfolio is diversified and a 32% discount to net asset value is a further comfort. Hold (74p).
Investors Chronicle
Buy into growth in the climate-friendly hydrogen business via industrial-gas specialist Linde ($248). The pandemic has not lifted all healthcare boats, with shares in surgical-products specialist Advanced Medical Solutions tumbling due to the widespread cancellation of elective surgeries. Yet sentiment should improve when business returns to normal, so take the opportunity to buy in (215p).
The Mail on Sunday
More people are cooking at home, generating new business for Cranswick, one of Britain’s leading pork producers. Dividends have increased annually for the past three decades. Shareholders may wish to cash in some of their profits but should keep “at least 50%” of their stake for the long term (3,768p).
The Times
Franco Manca pizza-owner Fulham Shore has had “two record weeks of trading” thanks to the restaurant-subsidy scheme and should emerge strongly from the crisis as rivals fall away. Buy (8.5p).
-
Child benefit tax return rules are changing – what is the high income child benefit charge?High-earning parents will soon be spared the hassle of filing a tax return to pay back child benefit. We explain what’s changing and how the high income child benefit charge (HICBC) works
-
Palmer Luckey: the billionaire flame of the westProfile Palmer Luckey started Oculus, the virtual-reality headset business, and sold it to Facebook for $2bn. Now he’s set his sights on the arms race.
-
Large cap stocks start to struggle – is it time for investors to reassess their focus?Buying quality large caps worked very well last decade. A more volatile world will be a bigger challenge for these star stocks, says Cris Sholto Heaton
-
How to generate income with fixed-interest investmentsPublic debt is overvalued, but other fixed-interest investments now look like a bargain, says Max King
-
Three top-notch Taiwanese companies cashing in on the advent of AIOpinion Eric Chan, investment director and co-manager of the Aberdeen Asian Income Fund, highlights three potential Taiwanese winners in the technology industry
-
Weight-loss drugs could revolutionise the economy – the investments to buy nowThe new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with food and revolutionise the economy
-
Find tomorrow’s Asian giants while they are still smaller companiesOpinion Nitin Bajaj, portfolio manager of the Fidelity Asian Values trust, picks three Asian companies to invest in.
-
AI will maintain Moody’s market lead, says Stephen ConnollyOpinion Veteran data provider Moody's has adapted well to the modern world, and is one of Warren Buffett’s longest-held investments
-
Is BlackRock World Mining gearing for a recovery?Opinion After a frustrating year, BlackRock World Mining is positioned for growth and to capitalise on the sector's recovery
-
Should you limit exposure to US tech stocks?An end to the AI boom would shake both US funds and global trackers. Here’s one way to trim exposure to US tech stocks
